Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.105 USD | -3.41% | -10.78% | -68.28% |
Apr. 16 | Windtree Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apr. 11 | North American Morning Briefing : Stock Futures -2- | DJ |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 2.09M |
---|---|---|---|---|---|
Net income 2024 * | -21M | Net income 2025 * | -29M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.24
x | P/E ratio 2025 * |
-0.35
x | Employees | 20 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.99% |
Latest transcript on Windtree Therapeutics, Inc.
1 day | -3.41% | ||
1 week | -10.78% | ||
Current month | -18.95% | ||
1 month | -24.68% | ||
3 months | -27.94% | ||
6 months | -75.99% | ||
Current year | -68.28% |
Managers | Title | Age | Since |
---|---|---|---|
Craig Fraser
CEO | Chief Executive Officer | 59 | 16-01-31 |
Eric Curtis
COO | Chief Operating Officer | 56 | 20-03-08 |
George Cox
CTO | Chief Tech/Sci/R&D Officer | 73 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Scott
BRD | Director/Board Member | 70 | 21-02-02 |
Mark Strobeck
BRD | Director/Board Member | 53 | 23-06-21 |
Leslie Williams
BRD | Director/Board Member | 64 | 21-02-02 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-22 | 4.105 | -3.41% | 19,184 |
24-05-21 | 4.25 | -2.75% | 7,359 |
24-05-20 | 4.37 | -2.67% | 24,758 |
24-05-17 | 4.49 | +4.42% | 8,041 |
24-05-16 | 4.3 | -6.55% | 11,333 |
Delayed Quote Nasdaq, May 22, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-68.28% | 2.09M | |
+64.23% | 62.59B | |
-2.31% | 41.18B | |
+45.49% | 40.29B | |
-8.29% | 27.9B | |
+11.97% | 26.21B | |
-21.16% | 19.09B | |
+7.54% | 13.08B | |
+25.72% | 12.26B | |
+27.17% | 12.05B |
- Stock Market
- Equities
- WINT Stock